Post ERCP pancreatitis Prediction System using a "Big 5" simple score for clinical decision-making in immediately after ERCP: a multicenter, prospective validation study

Post ERCP pancreatitis Prediction System using a "Big 5" simple score for clinical decision-making in immediately after ERCP: a multicenter, prospective validation study - PEP Prediction System using a "Big 5" simple score for clinical decision-making in immediately after ERCP

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043860

Enrollment

3500

Registered

2021-04-08

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo ERCP with trans-papilla.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Consecutive patients with suspected hepatobiliary-pancreatic disorders who undergo trans-papillary ERCP attempts. 2. Patients who are obtained written informed consent to undergo ERCP.

Exclusion criteria

Exclusion criteria: Patients or patients' family who reject the participation in this study, when the opportunity to opt out of this study participation was also provided.

Design outcomes

Primary

Measure	Time frame
To verify the usefulness and external validity of this scoring system, we evaluate predictive diagnostic ability using Receiver Operating Characteristic analysis and the area under the curve.	—

Countries

Japan

Contacts

Public ContactMasafumi Chiba

The Jikei University School of Medicine, Tokyo, Japan Department of Endoscopy

ccl09720@gmail.com334331113181

Outcome results